# sources

title: psychologytoday.com: Glp 1 anti obesity rx and alcohol and substance use disorders
node_name: Mesolimbic Dopamine Reward Suppression via GLP-1
created_at: 2026-06-20 13:06:10
url:
https://www.psychologytoday.com/us/blog/addiction-outlook/202602/glp-1-anti-obesity-rx-and-alcohol-and-substance-use-disorders


title: cms.gov: Coming soon cms provide 50 monthly access glp 1 medications medicare beneficiaries
node_name: Medicare GLP-1 Bridge Program
created_at: 2026-06-20 13:06:10
url:
https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries


title: kff.org: What to know about the balance model for glp 1s in medicare and medicaid
node_name: Medicare GLP-1 Bridge Program
created_at: 2026-06-20 13:06:10
url:
https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/


title: ncoa.org: Expanding access to weight loss medications the medicare glp 1 bridge program
node_name: Medicare GLP-1 Bridge Program
created_at: 2026-06-20 13:06:10
url:
https://www.ncoa.org/article/expanding-access-to-weight-loss-medications-the-medicare-glp-1-bridge-program/


title: uchicagomedicine.org: Projected medicare spending on glp 1 drugs
node_name: GLP-1 Medicare Net Cost Paradox
created_at: 2026-06-20 13:06:10
url:
https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/projected-medicare-spending-on-glp-1-drugs


title: bakeryandsnacks.com: Snack industry faces 2025 reset amid glp 1 inflation
node_name: Ultra-Processed Food Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://www.bakeryandsnacks.com/Article/2025/05/12/snack-industry-faces-2025-reset-amid-glp-1-inflation/


title: foodnavigator-usa.com: Soup to nuts podcast how will glp 1s reshape food in 2026
node_name: Ultra-Processed Food Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://www.foodnavigator-usa.com/Article/2025/12/15/soup-to-nuts-podcast-how-will-glp-1s-reshape-food-in-2026/


node_name: Most Favored Nation GLP-1 Pricing Mechanism
created_at: 2026-06-20 13:06:10
url:
https://www.drugdiscoverytrends.com/novo-slashes-us-glp-1-prices-by-up-to-70-but-2026-semaglutide-revenue-could-hold-steady-or-even-grow/

title:
drugdiscoverytrends.com: Novo slashes us glp 1 prices by up to 70 but 2026 semaglutide revenue could hold steady or even grow


title: orrick.com: FDA Moves to Shut the Door on Large Scale Compounding of GLP1 Drugs
node_name: Compounding Pharmacy GLP-1 Shadow Market
created_at: 2026-06-20 13:06:10
url:
https://www.orrick.com/en/Insights/2026/05/FDA-Moves-to-Shut-the-Door-on-Large-Scale-Compounding-of-GLP1-Drugs


title: czapp.com: Ozempics patent protection starts to expire in 2026 what next
node_name: GLP-1 Semaglutide Patent Fortress Strategy
created_at: 2026-06-20 13:06:10
url:
https://www.czapp.com/analyst-insights/ozempics-patent-protection-starts-to-expire-in-2026-what-next/


title: medicarerights.org: Medicare trust fund shows little change sustainability must be the focus
node_name: Medicare Part A Hospital Insurance Trust Fund Cliff
created_at: 2026-06-20 13:06:10
url:
https://www.medicarerights.org/medicare-watch/2026/06/11/medicare-trust-fund-shows-little-change-sustainability-must-be-the-focus


title: evaluate.com: Obesity and glp 1 dealmaking strategic trends and market signals
node_name: GLP-1 Pharma Arms Race and M&A Wave
created_at: 2026-06-20 13:06:10
url:
https://www.evaluate.com/thought-leadership/obesity-and-glp-1-dealmaking-strategic-trends-and-market-signals/


title: foxbusiness.com: Target beefs up protein supplement offerings capitalizing weight loss drug trend
node_name: GLP-1 Pharma Arms Race and M&A Wave
created_at: 2026-06-20 13:06:10
url:
https://www.foxbusiness.com/lifestyle/target-beefs-up-protein-supplement-offerings-capitalizing-weight-loss-drug-trend


title: fticonsulting.com: Reshaping food business strategies weight loss drug era
node_name: GLP-1 Pharma Arms Race and M&A Wave
created_at: 2026-06-20 13:06:10
url:
https://www.fticonsulting.com/insights/articles/reshaping-food-business-strategies-weight-loss-drug-era


title: cer.econ.columbia.edu: Novo nordisk economy denmarks growing dependence single pharma giant
node_name: Novo Nordisk Denmark Economic Monoculture
created_at: 2026-06-20 13:06:10
url:
https://cer.econ.columbia.edu/news/novo-nordisk-economy-denmarks-growing-dependence-single-pharma-giant


title: standrewseconomist.com: When one company rules the fragility of denmarks novo led economy
node_name: Novo Nordisk Denmark Economic Monoculture
created_at: 2026-06-20 13:06:10
url:
https://standrewseconomist.com/2025/02/14/when-one-company-rules-the-fragility-of-denmarks-novo-led-economy/


node_name: Novo Nordisk Denmark Economic Monoculture
created_at: 2026-06-20 13:06:10
url:
https://www.ainvest.com/news/novo-nordisk-downturn-implications-danish-economic-growth-global-biopharma-investment-strategy-2508/

title:
ainvest.com: Novo nordisk downturn implications danish economic growth global biopharma investment strategy 2508


node_name: MASH Semaglutide FDA Approval 2025
created_at: 2026-06-20 13:06:10
url:
https://www.aasld.org/aasld-applauds-fda-approval-first-glp-1-therapy-mash-expanding-use-popular-weight-loss-drug-liver

title:
aasld.org: Aasld applauds fda approval first glp 1 therapy mash expanding use popular weight loss drug liver


title: finviz.com: Mcdonalds tests high protein menu as glp 1 weight loss drug users surge
node_name: Restaurant Industry GLP-1 Menu Adaptation
created_at: 2026-06-20 13:06:10
url:
https://finviz.com/news/308676/mcdonalds-tests-high-protein-menu-as-glp-1-weight-loss-drug-users-surge


title: shrm.org: Glp 1 drugs reduce health costs employers over long term
node_name: Employer GLP-1 Coverage ROI Paradox
created_at: 2026-06-20 13:06:10
url:
https://www.shrm.org/topics-tools/news/benefits-compensation/glp-1-drugs-reduce-health-costs-employers-over-long-term


title: phti.org: PHTI Employer Approaches to GLP 1 Coverage Market Trend Report
node_name: Employer GLP-1 Coverage ROI Paradox
created_at: 2026-06-20 13:06:10
url:
https://phti.org/wp-content/uploads/sites/3/2025/12/PHTI-Employer-Approaches-to-GLP-1-Coverage-Market-Trend-Report.pdf


node_name: Employer GLP-1 Coverage ROI Paradox
created_at: 2026-06-20 13:06:10
url:
https://www.ebri.org/content/glp-1-coverage-and-its-impact-on-employment-based-health-plan-premiums--a-simulation-based-analysis

title:
ebri.org: Glp 1 coverage and its impact on employment based health plan premiums a simulation based analysis


title: asmbs.org: As glp 1 use skyrockets and bariatric surgery slows most obesity goes untreated
node_name: Bariatric Surgery Industry GLP-1 Disruption
created_at: 2026-06-20 13:06:10
url:
https://asmbs.org/news_releases/as-glp-1-use-skyrockets-and-bariatric-surgery-slows-most-obesity-goes-untreated/


title: news-medical.net: US bariatric surgery rates drop significantly amid GLP 1 surge
node_name: Bariatric Surgery Industry GLP-1 Disruption
created_at: 2026-06-20 13:06:10
url:
https://www.news-medical.net/news/20260505/US-bariatric-surgery-rates-drop-significantly-amid-GLP-1-surge.aspx


title: usnews.com: Weight loss surgeries fall more than 20 as patients turn to glp 1 meds experts say
node_name: Bariatric Surgery Industry GLP-1 Disruption
created_at: 2026-06-20 13:06:10
url:
https://www.usnews.com/news/health-news/articles/2026-05-06/weight-loss-surgeries-fall-more-than-20-as-patients-turn-to-glp-1-meds-experts-say


title: theglobeandmail.com: Could glp 1 drugs make resmed s cpap machines obsolete
node_name: GLP-1 Sleep Apnea CPAP Industry Disruption
created_at: 2026-06-20 13:06:10
url:
https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/36079676/could-glp-1-drugs-make-resmed-s-cpap-machines-obsolete/


node_name: CBO 10-Year Budget Window Preventive Care Bias
created_at: 2026-06-20 13:06:10
url:
https://budget.house.gov/press-release/budget-republicans-obernolte-and-carter-introduce-bill-to-improve-cbo-scoring-of-preventative-health-measures

title:
budget.house.gov: Budget republicans obernolte and carter introduce bill to improve cbo scoring of preventative health measures


title: acefitness.org: Glp 1s and lean mass what the research shows
node_name: GLP-1 Sarcopenia Risk and Protein Economy
created_at: 2026-06-20 13:06:10
url:
https://www.acefitness.org/continuing-education/certified/june-2025/8892/glp-1s-and-lean-mass-what-the-research-shows/


title: fiercepharma.com: Medicare unveils price reductions 15 drugs including novos semaglutide
node_name: IRA Medicare Drug Price Negotiation for GLP-1s
created_at: 2026-06-20 13:06:10
url:
https://www.fiercepharma.com/pharma/medicare-unveils-price-reductions-15-drugs-including-novos-semaglutide


title: medicalnewstoday.com: Weight loss drugs glp 1 slash risk 4 types cancer 50 or more study
node_name: GLP-1 Obesity-Related Cancer Risk Reduction
created_at: 2026-06-20 13:06:10
url:
https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk-4-types-cancer-50-or-more-study


node_name: GLP-1 Obesity-Related Cancer Risk Reduction
created_at: 2026-06-20 13:06:10
url:
https://www.oncology-central.com/asco-2026-glp-1s-could-reduce-the-risk-of-some-obesity-related-cancers-progressing/

title:
oncology-central.com: Asco 2026 glp 1s could reduce the risk of some obesity related cancers progressing


title: neurologylive.com: Glp 1 semaglutide fails outperform placebo phase 3 evoke trial ad
node_name: GLP-1 Alzheimer's Prevention vs Treatment Divide
created_at: 2026-06-20 13:06:10
url:
https://www.neurologylive.com/view/glp-1-semaglutide-fails-outperform-placebo-phase-3-evoke-trial-ad


title: imperial.ac.uk: Weight loss drugs and alzheimers disease is there hope for future
node_name: GLP-1 Alzheimer's Prevention vs Treatment Divide
created_at: 2026-06-20 13:06:10
url:
https://www.imperial.ac.uk/news/articles/medicine/brain-sciences/2026/weight-loss-drugs-and-alzheimers-disease--is-there-hope-for-future-/


title: investor.lilly.com: Fda approves lillys foundayotm orforglipron only glp 1 pill
node_name: Orforglipron (Foundayo) Oral GLP-1 Democratization Event
created_at: 2026-06-20 13:06:10
url:
https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill


node_name: Orforglipron (Foundayo) Oral GLP-1 Democratization Event
created_at: 2026-06-20 13:06:10
url:
https://www.patientcareonline.com/view/fda-approves-orforglipron-first-oral-glp-1-receptor-agonist-for-weight-loss-with-no-food-or-water-restrictions

title:
patientcareonline.com: Fda approves orforglipron first oral glp 1 receptor agonist for weight loss with no food or water restrictions


title: swissre.com: 3f8ec083 2b76 4eea 88cb e5af644e045d
node_name: Swiss Re GLP-1 Mortality Reduction Thesis
created_at: 2026-06-20 13:06:10
url:
https://www.swissre.com/press-release/GLP-1-drugs-may-reduce-mortality-by-up-to-6-4-in-the-US-by-2045/3f8ec083-2b76-4eea-88cb-e5af644e045d


title: insurancenewsnet.com: Swiss re study glp 1 drugs could cut u s mortality by staggering 6 4 by 2045
node_name: Swiss Re GLP-1 Mortality Reduction Thesis
created_at: 2026-06-20 13:06:10
url:
https://insurancenewsnet.com/innarticle/swiss-re-study-glp-1-drugs-could-cut-u-s-mortality-by-staggering-6-4-by-2045


node_name: Agricultural Commodity GLP-1 Demand Cascade
created_at: 2026-06-20 13:06:10
url:
https://farmdocdaily.illinois.edu/2025/03/consumers-expectations-about-glp-1-drugs-economic-impact-on-food-system-players.html

title:
farmdocdaily.illinois.edu: Consumers expectations about glp 1 drugs economic impact on food system players


node_name: Employer GLP-1 Coverage Fragmentation Crisis
created_at: 2026-06-20 13:06:10
url:
https://www.mercer.com/en-us/about/newsroom/employers-and-workers-face-affordability-crunch-as-health-insurnace-cost-is-expected-to-exceed-18500-per-employee-in-2026/

title:
mercer.com: Employers and workers face affordability crunch as health insurnace cost is expected to exceed 18500 per employee in 2026


node_name: GLP-1 Sarcopenic Obesity Weight Cycling Trap
created_at: 2026-06-20 13:06:10
url:
https://harvardsciencereview.org/2026/02/23/the-glp-1-aftermath-what-the-science-says-about-muscle-loss-and-cellular-aging/

title:
harvardsciencereview.org: The glp 1 aftermath what the science says about muscle loss and cellular aging


node_name: India Generic Semaglutide Explosion: Global Two-Tier GLP-1 Access
created_at: 2026-06-20 13:06:10
url:
https://www.business-standard.com/industry/news/sun-pharma-dr-reddy-s-glenmark-launch-generic-semaglutide-in-india-126032100221_1.html

title:
business-standard.com: Sun pharma dr reddy s glenmark launch generic semaglutide in india 126032100221 1


node_name: India Generic Semaglutide Explosion: Global Two-Tier GLP-1 Access
created_at: 2026-06-20 13:06:10
url:
https://www.businesstoday.in/industry/pharma/story/dr-reddys-launches-oral-semaglutide-tablets-at-rs99-per-pill-in-india-532551-2026-05-20

title:
businesstoday.in: Dr reddys launches oral semaglutide tablets at rs99 per pill in india 532551 2026 05 20


node_name: India Generic Semaglutide Explosion: Global Two-Tier GLP-1 Access
created_at: 2026-06-20 13:06:10
url:
https://www.pearceip.law/2026/03/21/generic-semaglutide-launches-in-india-including-by-dr-reddys-zydus-alkem-sun-pharma-glenmark/

title:
pearceip.law: Generic semaglutide launches in india including by dr reddys zydus alkem sun pharma glenmark


title: businessgrouphealth.org: 2026 employer health care strategy survey executive summary
node_name: GLP-1 Employer Productivity ROI vs Short-Term Cost Horizon
created_at: 2026-06-20 13:06:10
url:
https://www.businessgrouphealth.org/resources/2026-employer-health-care-strategy-survey-executive-summary


title: worldatwork.org: What does the data show on glp 1 prescribe rates coverage costs
node_name: GLP-1 Employer Productivity ROI vs Short-Term Cost Horizon
created_at: 2026-06-20 13:06:10
url:
https://worldatwork.org/publications/workspan-daily/what-does-the-data-show-on-glp-1-prescribe-rates-coverage-costs


node_name: GLP-1 Fill-Finish Manufacturing Industrial War
created_at: 2026-06-20 13:06:10
url:
https://www.fiercepharma.com/pharma/novo-holdings-antes-165b-poach-catalent-selling-three-fill-finish-sites-novo-nordisk

title:
fiercepharma.com: Novo holdings antes 165b poach catalent selling three fill finish sites novo nordisk


title: pharmtech.com: Overcoming fill finish capacity bottlenecks in automated pen injector assembly lines
node_name: GLP-1 Fill-Finish Manufacturing Industrial War
created_at: 2026-06-20 13:06:10
url:
https://www.pharmtech.com/view/overcoming-fill-finish-capacity-bottlenecks-in-automated-pen-injector-assembly-lines


title: foodnavigator-usa.com: Cpg brands cautiously adopt glp 1 friendly claims on packaging
node_name: GLP-1 Friendly CPG Category Emergence
created_at: 2026-06-20 13:06:10
url:
https://www.foodnavigator-usa.com/Article/2026/04/21/cpg-brands-cautiously-adopt-glp-1-friendly-claims-on-packaging/


node_name: Ozempic Baby Boom: GLP-1 Fertility Double-Edge
created_at: 2026-06-20 13:06:10
url:
https://www.pharmacytimes.com/view/so-called-ozempic-babies-raise-questions-about-unintended-effects-of-glp-1-inhibitors

title:
pharmacytimes.com: So called ozempic babies raise questions about unintended effects of glp 1 inhibitors


title: itif.org: A shot at a healthier future the transformative potential of glp 1s
node_name: GLP-1 GDP Productivity Multiplier
created_at: 2026-06-20 13:06:10
url:
https://itif.org/publications/2025/08/18/a-shot-at-a-healthier-future-the-transformative-potential-of-glp-1s/


title: medscape.com: Glp 1 uptake rises metabolic surgery rates decline 2026a1000fg5
node_name: Bariatric Surgery GLP-1 Cannibalization
created_at: 2026-06-20 13:06:10
url:
https://www.medscape.com/viewarticle/glp-1-uptake-rises-metabolic-surgery-rates-decline-2026a1000fg5


title: investor.lilly.com: Fda approves zepboundr tirzepatide first and only prescription
node_name: Zepbound OSA Approval: GLP-1 Multi-Indication Coverage Bypass
created_at: 2026-06-20 13:06:10
url:
https://investor.lilly.com/news-releases/news-release-details/fda-approves-zepboundr-tirzepatide-first-and-only-prescription


title: diabetes.org: Semaglutide reduced risk major kidney disease events 24 patients type 2
node_name: FLOW Trial: GLP-1 Diabetic CKD + Dialysis Industry Structural Threat
created_at: 2026-06-20 13:06:10
url:
https://diabetes.org/newsroom/press-releases/semaglutide-reduced-risk-major-kidney-disease-events-24-patients-type-2


node_name: TrumpRx MFN Direct-to-Consumer GLP-1 Platform
created_at: 2026-06-20 13:06:10
url:
https://www.amcp.org/letters-statements-analysis/federal-update-trump-administration-announces-deal-bring-most-favored-nation-pricing-glp-1s

title:
amcp.org: Federal update trump administration announces deal bring most favored nation pricing glp 1s


title: wtwco.com: Trumprx and glp 1s what this means for drug pricing and employer strategies
node_name: TrumpRx MFN Direct-to-Consumer GLP-1 Platform
created_at: 2026-06-20 13:06:10
url:
https://www.wtwco.com/en-us/insights/2025/12/trumprx-and-glp-1s-what-this-means-for-drug-pricing-and-employer-strategies


title: conference-board.org: Administration strikes deal on glp1 drug pricing and coverage
node_name: TrumpRx MFN Direct-to-Consumer GLP-1 Platform
created_at: 2026-06-20 13:06:10
url:
https://www.conference-board.org/research/CED-Newsletters-Alerts/administration-strikes-deal-on-glp1-drug-pricing-and-coverage


node_name: GLP-1 T2D Remission: Drug Dependency Paradox
created_at: 2026-06-20 13:06:10
url:
https://europe.ophthalmologytimes.com/view/diabetes-remission-glp-1-therapies-long-term-outcomes-diabetic-retinopathy

title:
europe.ophthalmologytimes.com: Diabetes remission glp 1 therapies long term outcomes diabetic retinopathy


node_name: GLP-1 Adherence Cliff: 64% Obesity-Only Dropout at Year One
created_at: 2026-06-20 13:06:10
url:
https://www.consultant360.com/exclusive/most-patients-discontinue-glp-1-drugs-within-year-higher-dropout-weight-loss-users

title:
consultant360.com: Most patients discontinue glp 1 drugs within year higher dropout weight loss users


node_name: Lancet Psychiatry 2026: GLP-1 Mental Health Net Benefit
created_at: 2026-06-20 13:06:10
url:
https://www.business-standard.com/health/ozempic-semaglutide-lowers-depression-anxiety-risk-lancet-study-126040800826_1.html

title:
business-standard.com: Ozempic semaglutide lowers depression anxiety risk lancet study 126040800826 1


title: psychiatryadvisor.com: Glp 1 receptor agonists linked to reduced risk for worsening mental illness
node_name: Lancet Psychiatry 2026: GLP-1 Mental Health Net Benefit
created_at: 2026-06-20 13:06:10
url:
https://www.psychiatryadvisor.com/news/glp-1-receptor-agonists-linked-to-reduced-risk-for-worsening-mental-illness/


title: clinicaltrialvanguard.com: The glp 1 mood signal is real but so is the psychiatric worsening risk
node_name: Lancet Psychiatry 2026: GLP-1 Mental Health Net Benefit
created_at: 2026-06-20 13:06:10
url:
https://www.clinicaltrialvanguard.com/article/psych-pulse/the-glp-1-mood-signal-is-real-but-so-is-the-psychiatric-worsening-risk/


title: aasld.org: Semaglutide improves histology mash phase 3
node_name: GLP-1 MASH Liver Disease Cascade Interruption
created_at: 2026-06-20 13:06:10
url:
https://www.aasld.org/liver-fellow-network/core-series/evidence-corner/semaglutide-improves-histology-mash-phase-3


title: usda.gov: Secretary rollins signs six new state waivers
node_name: MAHA SNAP Ultra-Processed Food Restriction Policy
created_at: 2026-06-20 13:06:10
url:
https://www.usda.gov/about-usda/news/press-releases/2025/12/10/secretary-rollins-signs-six-new-state-waivers


title: foodnavigator-usa.com: Snap reform advances usda tightens nutrition standards adds state waivers
node_name: MAHA SNAP Ultra-Processed Food Restriction Policy
created_at: 2026-06-20 13:06:10
url:
https://www.foodnavigator-usa.com/Article/2026/03/05/snap-reform-advances-usda-tightens-nutrition-standards-adds-state-waivers/


node_name: UPF Litigation: San Francisco v. Big Food Tobacco Playbook
created_at: 2026-06-20 13:06:10
url:
https://sfcityattorney.org/san-francisco-city-attorney-chiu-sues-largest-manufacturers-of-ultra-processed-foods/

title:
sfcityattorney.org: San francisco city attorney chiu sues largest manufacturers of ultra processed foods


title: nbcnews.com: San francisco sues ultra processed food makers rcna247027
node_name: UPF Litigation: San Francisco v. Big Food Tobacco Playbook
created_at: 2026-06-20 13:06:10
url:
https://www.nbcnews.com/health/health-news/san-francisco-sues-ultra-processed-food-makers-rcna247027


node_name: UPF Litigation: San Francisco v. Big Food Tobacco Playbook
created_at: 2026-06-20 13:06:10
url:
https://healthpolicy-watch.news/us-city-sues-ultra-processed-food-companies-seeking-restitution-for-health-costs/

title:
healthpolicy-watch.news: Us city sues ultra processed food companies seeking restitution for health costs


node_name: GLP-1 Mental Health Paradox: BDNF Antidepressant vs. Anhedonia Risk
created_at: 2026-06-20 13:06:10
url:
https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp

title:
fda.gov: Fda requests removal suicidal behavior and ideation warning glucagon peptide 1 receptor agonist glp


title: SEC: A2026q1earningsreleaseex 9
node_name: UPF Revenue Destruction Cascade: $52-62B CPG Loss by 2028
created_at: 2026-06-20 13:06:10
url:
https://www.sec.gov/Archives/edgar/data/0000021344/000162828026027723/a2026q1earningsreleaseex-9.htm


title: thedrinksbusiness.com: Glp 1 drugs reshape alcohol consumption and hospitality habits
node_name: Alcohol Industry GLP-1 Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://www.thedrinksbusiness.com/2026/04/glp-1-drugs-reshape-alcohol-consumption-and-hospitality-habits/


title: statnews.com: Weight loss drugs knee replacements fda cell gene therapy
node_name: GLP-1 Orthopedic Surgery Prevention + Bone Loss Paradox
created_at: 2026-06-20 13:06:10
url:
https://www.statnews.com/pharmalot/2026/06/03/weight-loss-drugs-knee-replacements-fda-cell-gene-therapy/


node_name: GLP-1 Orthopedic Surgery Prevention + Bone Loss Paradox
created_at: 2026-06-20 13:06:10
url:
https://aaos-annualmeeting-presskit.org/2026/research-news/studies-explore-glp-1-receptor-agonist-use-and-its-impact-on-long-term-musculoskeletal-health/

title:
aaos-annualmeeting-presskit.org: Studies explore glp 1 receptor agonist use and its impact on long term musculoskeletal health


node_name: GLP-1 Orthopedic Surgery Prevention + Bone Loss Paradox
created_at: 2026-06-20 13:06:10
url:
https://aaos-annualmeeting-presskit.org/2025/research-news/new-study-recommends-stopping-glp-1-agonists-14-days-before-total-joint-arthroplasty-to-reduce-anesthesia-risks/

title:
aaos-annualmeeting-presskit.org: New study recommends stopping glp 1 agonists 14 days before total joint arthroplasty to reduce anesthesia risks


node_name: GLP-1 Agricultural Commodity Demand Destruction Chain
created_at: 2026-06-20 13:06:10
url:
https://ctrlchain.com/en-us/blogs/the-ozempic-effect-how-glp-1-drugs-are-transforming-u.s.-food-beverage-and-pharma-logistics

title:
ctrlchain.com: The ozempic effect how glp 1 drugs are transforming u.s. food beverage and pharma logistics


title: aei.org: Big but not beautiful agricultural policy in the 2025 budget reconciliation bill
node_name: Farm Bill Corn/Sugar Subsidy vs. GLP-1 Demand Destruction Political Contradiction
created_at: 2026-06-20 13:06:10
url:
https://www.aei.org/research-products/report/big-but-not-beautiful-agricultural-policy-in-the-2025-budget-reconciliation-bill/


title: adanews.ada.org: Oral care considerations for patients using semaglutide similar medications
node_name: Ozempic Mouth: GLP-1 Bidirectional Dental Industry Impact
created_at: 2026-06-20 13:06:10
url:
https://adanews.ada.org/ada-news/2025/october/oral-care-considerations-for-patients-using-semaglutide-similar-medications/


title: theiwsr.com: Global beverage alcohol to drop further before recovering
node_name: GLP-1 Alcohol Industry Structural Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://www.theiwsr.com/insight/press-release/global-beverage-alcohol-to-drop-further-before-recovering/


title: foodnavigator.com: After glp 1 weight regain and foods next challenge
node_name: Weight Loss Industry Creative Destruction: GLP-1 Kills Its Predecessors
created_at: 2026-06-20 13:06:10
url:
https://www.foodnavigator.com/Article/2026/01/22/after-glp-1-weight-regain-and-foods-next-challenge/


title: news-medical.net: GLP 1 treatments may reduce knee replacement surgery rates
node_name: GLP-1 Orthopedic Surgery Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://www.news-medical.net/news/20260602/GLP-1-treatments-may-reduce-knee-replacement-surgery-rates.aspx


node_name: Agricultural Commodity Cascade: GLP-1 Demand Destruction
created_at: 2026-06-20 13:06:10
url:
https://abcnews4.com/news/nation-world/weight-loss-drugs-are-reshaping-us-agriculture-and-food-industry-glp1s-medicine-health-groceries

title:
abcnews4.com: Weight loss drugs are reshaping us agriculture and food industry glp1s medicine health groceries


title: bmjgroup.com: Glp 1 agonists linked to significantly lower long term risk of knee replacement
node_name: GLP-1 Orthopedic Surgery Cannibalization
created_at: 2026-06-20 13:06:10
url:
https://bmjgroup.com/glp-1-agonists-linked-to-significantly-lower-long-term-risk-of-knee-replacement/


node_name: WW International Chapter 11: Diet Industry Obsolescence Event
created_at: 2026-06-20 13:06:10
url:
https://mlq.ai/news/weightwatchers-files-for-chapter-11-bankruptcy-to-slash-115-billion-debt-amid-weight-loss-drug-disruption/

title:
mlq.ai: Weightwatchers files for chapter 11 bankruptcy to slash 115 billion debt amid weight loss drug disruption


node_name: SNAP Junk Food Restriction Wave: Parallel Obesity Policy Track
created_at: 2026-06-20 13:06:10
url:
https://www.coloradopolitics.com/2025/12/31/snap-recipients-in-five-states-will-be-banned-from-using-assistance-for-candy-and-soda-beginning-2026/

title:
coloradopolitics.com: Snap recipients in five states will be banned from using assistance for candy and soda beginning 2026


title: munichre.com: Glp 1 therapies and mortality risk implications for life insurers
node_name: Life Insurance vs Annuity GLP-1 Bifurcation
created_at: 2026-06-20 13:06:10
url:
https://www.munichre.com/us-life/en/insights/clinical-knowledge/glp-1-therapies-and-mortality-risk-implications-for-life-insurers.html


node_name: CMS BALANCE Model: Value-Based GLP-1 Payment
created_at: 2026-06-20 13:06:10
url:
https://www.cms.gov/newsroom/press-releases/cms-launches-voluntary-model-expand-access-life-changing-medicines-promote-healthier-living

title:
cms.gov: Cms launches voluntary model expand access life changing medicines promote healthier living


title: foodnavigator-usa.com: Glp1 disruption nestles strategy shift and reformulation pressure
node_name: Food Industry GLP-1 Adaptation: Protein-Forward Pivot
created_at: 2026-06-20 13:06:10
url:
https://www.foodnavigator-usa.com/Article/2026/05/01/glp1-disruption-nestles-strategy-shift-and-reformulation-pressure/


title: realagriculture.com: How glp 1s will shift consumer food habits and why it matters for agriculture
node_name: GLP-1 Agricultural Commodity Demand Cascade
created_at: 2026-06-20 13:06:10
url:
https://www.realagriculture.com/2026/01/how-glp-1s-will-shift-consumer-food-habits-and-why-it-matters-for-agriculture/


title: cobank.com: Food and beverage companies reckon with sinking sales
node_name: Ultra-Processed Food Industry Structural Disruption
created_at: 2026-06-20 13:06:10
url:
https://www.cobank.com/knowledge-exchange/food-and-beverage/food-and-beverage-companies-reckon-with-sinking-sales


title: washingtonexaminer.com: Make snap maha junk food ban permanent
node_name: MAHA-GLP-1 Political Credit Attribution Paradox
created_at: 2026-06-20 13:06:10
url:
https://www.washingtonexaminer.com/opinion/editorials/3494522/make-snap-maha-junk-food-ban-permanent/


node_name: MAHA-GLP-1 Political Credit Attribution Paradox
created_at: 2026-06-20 13:06:10
url:
https://centerforhealthjournalism.org/our-work/insights/health-divide-will-snap-junk-food-bans-make-people-healthier-or-hungrier

title:
centerforhealthjournalism.org: Health divide will snap junk food bans make people healthier or hungrier


title: swissre.com: Future of metabolic health and weight loss drugs
node_name: GLP-1 Defined Benefit Pension Longevity Liability Shock
created_at: 2026-06-20 13:06:10
url:
https://www.swissre.com/risk-knowledge/living-longer-healthier-lives/future-of-metabolic-health-and-weight-loss-drugs.html


title: benefitsandpensionsmonitor.com: 392827
node_name: Fast Food Employment-Obesity Inequality Inversion
created_at: 2026-06-20 13:06:10
url:
https://www.benefitsandpensionsmonitor.com/news/industry-news/glp-1-drugs-take-a-bite-out-of-fast-food-returns/392827


title: cspdailynews.com: Foodservice labor struggle will intensify 2026 technomic says
node_name: Fast Food Employment-Obesity Inequality Inversion
created_at: 2026-06-20 13:06:10
url:
https://www.cspdailynews.com/foodservice/foodservice-labor-struggle-will-intensify-2026-technomic-says


node_name: Fast Food Employment-Obesity Inequality Inversion
created_at: 2026-06-20 13:06:10
url:
https://www.ebri.org/content/full/glp-1-coverage-and-its-impact-on-employment-based-health-plan-premiums--a-simulation-based-analysis

title:
ebri.org: Glp 1 coverage and its impact on employment based health plan premiums a simulation based analysis


node_name: TrumpRx MFN Three-Tier GLP-1 Pricing Architecture
created_at: 2026-06-20 13:06:10
url:
https://www.pharmacytimes.com/view/eli-lilly-novo-nordisk-strike-mfn-deals-with-trump-administration-to-lower-glp-1-prices

title:
pharmacytimes.com: Eli lilly novo nordisk strike mfn deals with trump administration to lower glp 1 prices


title: mercer.com: Trump announces lower glp 1 prices will employer plans see them too
node_name: TrumpRx MFN Three-Tier GLP-1 Pricing Architecture
created_at: 2026-06-20 13:06:10
url:
https://www.mercer.com/en-us/insights/us-health-news/trump-announces-lower-glp-1-prices-will-employer-plans-see-them-too/


node_name: GLP-1 Caloric Demand Destruction: 20 Billion Calories/Day
created_at: 2026-06-20 13:06:10
url:
https://markets.financialcontent.com/clarkebroadcasting.mymotherlode/article/gnwcq-2024-10-9-americans-expected-to-reduce-calorie-intake-by-trillions-as-glp-1-usage-rises-according-to-new-study

title:
markets.financialcontent.com: Gnwcq 2024 10 9 americans expected to reduce calorie intake by trillions as glp 1 usage rises according to new study


title: usrds-adr.niddk.nih.gov: 9 healthcare expenditures for persons with esrd
node_name: GLP-1 CKD/ESRD Disruption: FLOW Trial and Dialysis Industry Paradox
created_at: 2026-06-20 13:06:10
url:
https://usrds-adr.niddk.nih.gov/2024/end-stage-renal-disease/9-healthcare-expenditures-for-persons-with-esrd


title: ajmc.com: Trump announces deals with eli lilly novo nordisk for lower weight loss drug prices
node_name: TrumpRx MFN Platform: Direct-to-Consumer GLP-1 Pricing Revolution
created_at: 2026-06-20 13:06:10
url:
https://www.ajmc.com/view/trump-announces-deals-with-eli-lilly-novo-nordisk-for-lower-weight-loss-drug-prices


node_name: TrumpRx MFN Platform: Direct-to-Consumer GLP-1 Pricing Revolution
created_at: 2026-06-20 13:06:10
url:
https://www.pharmacytimes.com/view/eli-lily-novo-nordisk-strike-mfn-deals-with-trump-administration-to-lower-glp-1-prices

title:
pharmacytimes.com: Eli lily novo nordisk strike mfn deals with trump administration to lower glp 1 prices


node_name: GLP-1 Cross-Addiction Suppression Mechanism
created_at: 2026-06-20 13:06:10
url:
https://www.pharmacytimes.com/view/glp-1-receptor-agonists-show-promise-across-alcohol-opioid-and-tobacco-use-disorders

title:
pharmacytimes.com: Glp 1 receptor agonists show promise across alcohol opioid and tobacco use disorders


title: Science: Obesity drugs linked lower addiction rates large study veterans
node_name: GLP-1 Cross-Addiction Suppression Mechanism
created_at: 2026-06-20 13:06:10
url:
https://www.science.org/content/article/obesity-drugs-linked-lower-addiction-rates-large-study-veterans


